Physicians may now be better at detecting breast cancer than ever before, but much more work remains to ensure accurate diagnosis is possible and especially to assess future risk. That's why researchers from Germany have been working to develop a new test of gene action to predict cancer risk both at first diagnosis and into the future. In a new research report appearing in the December 2012 issue of The FASEB Journal, researchers show that the various genetic switches, which are turned on and off in the regular development of every cell in the body, can be analyzed in minute detail to determine the presence or risk of breast cancer growth.
"We hope that our results help to develop tools to identify breast cancer patients when tumors are still small, and eventually curable," said Clarissa Gerhauser, Ph.D., a researcher involved in the work from the Division of Epigenomics and Cancer Risk Factors at the German Cancer Research Center in Heidelberg, Germany. "These tools might hopefully also help to predict the progression of tumor development and guide decisions on cancer treatment."
To make this advance, Gerhauser and colleagues extracted DNA from 10 small tumor tissue samples and 10 normal breast tissues from breast cancer patients. They made small fragments from the extracted DNA and identified the genetic switches within those fragments. By comparing the results from various combinations of DNA fragments, scientists discovered which switches were more prevalent in tumor tissue than in normal breast tissue. The methods used to quantify the switches are extremely sensitive, making it feasible that small biopsies would be sufficient for analysis and testing.
"This is a milestone. The method described detects activity at the genetic level, which often occurs well before any outward symptoms occur," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "Not only could this allow for earlier diagnosis of breast cancer and more accurate risk assessment, but eventually, this technique might be used in other types of cancer as well."
Federation of American Societies for Experimental Biology: http://www.faseb.org
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Look into the jaws of a Mosasaurus and you will gaze into a nightmare.
Although it's far from the sort of brain transplant beloved by science fiction enthusiasts, scientists have taken one step in that direction: they have spliced a key human brain gene into mice.
A network in the brain that helps control daydreaming seem to be slower to develop in children with attention deficit hyperactivity disorder.
Close to real-time tracking of deadly superbugs such as MRSA promises to close down outbreaks faster and save lives
Western Australia's shark cull is to be halted after the state's environmental regulator advised against it, citing "scientific uncertainty".
23andMe hired new executives experienced in health regulation to oversee FDA approval of its genetics diagnostics kit
For those who think there are not enough hours in the day, researchers may have just offered you a solution. The brain can continue tasks even while asleep, a study finds. Texting not included, alas.
It roamed land and sea and snacked on giant fish. The first few spinosaurus bones were discovered a century ago, but destroyed in WWII. A more complete, second specimen reveals a terrifying predator.
Geneticist Wendy Chung describes what it's like to chip away at the mysteries of autism, and the excitement of uncovering tiny but critical clues.
Thin area of skull allows light into brain